KR850006131A - 안정화된 제약 조성물 - Google Patents

안정화된 제약 조성물 Download PDF

Info

Publication number
KR850006131A
KR850006131A KR1019850001346A KR850001346A KR850006131A KR 850006131 A KR850006131 A KR 850006131A KR 1019850001346 A KR1019850001346 A KR 1019850001346A KR 850001346 A KR850001346 A KR 850001346A KR 850006131 A KR850006131 A KR 850006131A
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
imidazolium
carbamoyl
oleate
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019850001346A
Other languages
English (en)
Korean (ko)
Inventor
케이이치(외 2) 가토오
Original Assignee
구로다 요시히로
스미토모 세이야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 구로다 요시히로, 스미토모 세이야쿠 가부시키가이샤 filed Critical 구로다 요시히로
Publication of KR850006131A publication Critical patent/KR850006131A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019850001346A 1984-03-05 1985-03-04 안정화된 제약 조성물 Withdrawn KR850006131A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59043265A JPS60185727A (ja) 1984-03-05 1984-03-05 ４−カルバモイルイミダゾリウム−５−オレ−ト製剤の安定化法
JP43265 1984-03-05

Publications (1)

Publication Number Publication Date
KR850006131A true KR850006131A (ko) 1985-10-02

Family

ID=12659008

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850001346A Withdrawn KR850006131A (ko) 1984-03-05 1985-03-04 안정화된 제약 조성물

Country Status (5)

Country Link
EP (1) EP0159777A1 (enExample)
JP (1) JPS60185727A (enExample)
KR (1) KR850006131A (enExample)
CA (1) CA1235065A (enExample)
ES (1) ES8700936A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950010150B1 (ko) * 1986-01-14 1995-09-11 쥬우가이세이야꾸 가부시끼가이샤 니코란딜 함유 주사제의 안정화 방법
JP5266010B2 (ja) 2007-09-14 2013-08-21 富士フイルム株式会社 ４−カルバモイル−５−ヒドロキシ−イミダゾール誘導体のスルホン酸塩化合物
JP5458777B2 (ja) 2009-09-28 2014-04-02 株式会社ジェイテクト ダブルカルダンジョイントのカップリングヨーク
JP2013082706A (ja) * 2011-09-28 2013-05-09 Fujifilm Corp ５−ヒドロキシ−１ｈ−イミダゾール−４−カルボキサミド水和物の結晶
BR112014007436A2 (pt) 2011-09-28 2017-04-04 Fujifilm Corp cristal de 5-hidróxi-1h-imidazola-4-carboxamida:3/4 hidrato, método para a produção do mesmo e cristal de 5-hidróxi-1h-imidazola-4-carboxamida hidrato
TWI573791B (zh) * 2011-09-28 2017-03-11 富士軟片股份有限公司 ５－羥基－１ｈ－咪唑－４－甲醯胺．３／４水合物及其結晶之製造方法
RU2642670C2 (ru) 2013-01-15 2018-01-25 Фуджифилм Корпорэйшн Упакованный продукт твердого препарата, содержащего 5-гидрокси-1н-имидазол-4-карбоксамид или его соль, или его гидрат
LT2946780T (lt) 2013-01-15 2017-06-12 Fujifilm Corporation Tabletė, turinti 5-hidroksi-1h-imidazol-4-karboksamido
BR112015015282A2 (pt) * 2013-01-15 2017-07-11 Fujifilm Corp sulfato de 5 - hidróxi - 1h - imidazol - 4 - carboxamida
WO2019082898A1 (ja) 2017-10-27 2019-05-02 富士フイルム株式会社 ５－ヒドロキシ－１ｈ－イミダゾール－４－カルボキサミド・３／４水和物の製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4181731A (en) * 1976-09-07 1980-01-01 Sumitomo Chemical Company, Limited Novel therapeutic application of 4-carbamoyl-5-hydroxyimidazole
EP0051962B1 (en) * 1980-11-05 1988-08-24 Sumitomo Chemical Company, Limited Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate

Also Published As

Publication number Publication date
ES540907A0 (es) 1986-11-16
EP0159777A1 (en) 1985-10-30
ES8700936A1 (es) 1986-11-16
JPH0137376B2 (enExample) 1989-08-07
CA1235065A (en) 1988-04-12
JPS60185727A (ja) 1985-09-21

Similar Documents

Publication Publication Date Title
US3304230A (en) Liquid aerosol propellant solutions of fatty acid salts of physiologically active amines
KR880002508A (ko) 세포내 지방입자(리포솜)의 제조방법 및 조성물
KR850006131A (ko) 안정화된 제약 조성물
KR830005850A (ko) 경구 투여용, 특히 소아경구 투여용 마이크로 캡슐화 바캄피실린산 부가염의 현탁액
YU235987A (sh) Postupak za dobijanje topikalne anti-inflamatorne/analgezične farmaceutske trake
KR910007536A (ko) 외용 피부 제제
KR910011645A (ko) 수성 베타 수산화 코발트(ii) 및 그의 제조방법
BR8601025A (pt) Composto explosivo estavel quando armazenado e metodo de preparacao de um composto explosivo pela mistura de particulas de nitrato inorganico com uma pasta aquosa
GB1382939A (en) Heterocyclic benzamide compounds processes for making them and compositions containing them
KR860003830A (ko) 가용화한 백금화합물 및 그 제조방법
KR970027048A (ko) 안정한 결정질 테트라하이드로엽산염
IE41052B1 (en) Crop protection composition and method of application, whereby the drift of spraying liquids may be reduced
JPS6416724A (en) Stable and injectable vinca dimer salt solution
KR910009382A (ko) 수용성 납땜용 프럭스
ES477657A1 (es) Procedimiento para preparar acidos azulminicos.
BR0108446A (pt) Produtos à base de uva, fortificados com cálcio e processos para prepará-los
KR880009975A (ko) 화합물
KR930012018A (ko) 약제학적 조성물
KR930023338A (ko) 데포우 제제
DE3264906D1 (en) Aminoglycoside derivatives, processes for their production, pharmaceutical compositions containing them and such derivatives for use as pharmaceuticals
US4616022A (en) Procaterol stabilization
KR850001692A (ko) 장용성(腸溶性) 코우팅액
GB1522571A (en) Process for producing stable solutions of a sulphonamide and a potentiator
KR870700024A (ko) 약, 비타민 또는 왁진의 근육내 주사용 제제
GB1483507A (en) Aqueous food base

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19850304

PG1501 Laying open of application
PC1202 Submission of document of withdrawal before decision of registration

Comment text: [Withdrawal of Procedure relating to Patent, etc.] Withdrawal (Abandonment)

Patent event code: PC12021R01D

Patent event date: 19880706

WITB Written withdrawal of application